📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target. (2017)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aan2514

PubMed Identifier: 29021166

Publication URI: http://europepmc.org/abstract/MED/29021166

Type: Journal Article/Review

Volume: 9

Parent Publication: Science translational medicine

Issue: 411

ISSN: 1946-6234